IL6 and neoplasm: Both IL-6 and IL-8 contribute to the recruitment of myeloid-derived suppressor cells to the TME, hindering the anti-tumor activity of cytotoxic T cells, and have been associated with poor clinical outcomes across different tumor types [65–69].